Boston Scientific Corporation (BSX)

NYSE: BSX · Real-Time Price · USD

46.73

+0.73 (1.59%)

At close: Jul 31, 2026, 4:00 PM EDT

46.70

-0.03 (-0.06%)

After-hours: Jul 31, 2026, 7:56 PM EDT

Boston Scientific Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	20,996	20,074	16,747	14,240	12,682	11,888
Revenue Growth	13.53%	19.87%	17.61%	12.29%	6.68%	19.92%
Cost of Revenue	6,315	6,221	5,257	4,345	3,956	3,711
Gross Profit	14,683	13,854	11,490	9,896	8,727	8,177
Selling, General & Admin	7,159	6,887	5,984	5,190	4,520	4,359
Depreciation & Amortization Expenses	918	897	856	828	803	741
Research & Development	2,153	2,052	1,615	1,414	1,323	1,204
Other Operating Expenses	33	405	430	120	433	675
Total Operating Expenses	10,263	10,241	8,885	7,552	7,079	6,979
Operating Income	4,152	3,613	2,603	2,343	1,649	1,199
Interest Expense	-363	-349	-305	-265	-470	-341
Other Non-Operating Income (Expense)	70	121	-16	-93	-38	218
Total Non-Operating Income (Expense)	-293	-228	-321	-358	-508	-123
Pretax Income	3,861	3,385	2,282	1,985	1,141	1,076
Provision for Income Taxes	192	493	436	393	443	36
Net Income	3,669	2,892	1,846	1,592	698	1,040
Minority Interest in Earnings	-6	-6	-8	-1	-	-
Net Income Attributable to Preferred Dividends	-	-	-	23	55	55
Net Income to Common	3,675	2,898	1,853	1,570	642	985
Net Income Growth	46.71%	56.39%	18.02%	144.55%	-34.82%	-
Shares Outstanding (Basic)	1,480	1,480	1,472	1,453	1,431	1,431
Shares Outstanding (Diluted)	1,490	1,495	1,486	1,464	1,440	1,442
Shares Change	-0.05%	0.58%	1.53%	1.65%	-0.16%	1.79%
EPS (Basic)	2.48	1.96	1.26	1.08	0.45	0.72
EPS (Diluted)	2.47	1.94	1.25	1.07	0.45	0.72
EPS Growth	47.02%	55.20%	16.82%	137.78%	-37.50%	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-	3,658	2,645	1,792	938	1,316
Free Cash Flow Growth	-	38.30%	47.60%	91.05%	-28.72%	16.25%
Free Cash Flow Per Share	-	2.45	1.78	1.22	0.65	0.91
Gross Margin	69.93%	69.01%	68.61%	69.49%	68.81%	68.78%
Operating Margin	19.78%	18.00%	15.54%	16.45%	13.00%	10.09%
Profit Margin	17.47%	14.41%	11.02%	11.18%	5.50%	8.75%
FCF Margin	-	18.22%	15.79%	12.58%	7.40%	11.07%
EBITDA	4,152	4,981	3,872	3,539	2,785	2,292
EBITDA Margin	19.78%	24.81%	23.12%	24.85%	21.96%	19.28%
EBIT	4,152	3,613	2,603	2,343	1,649	1,199
EBIT Margin	19.78%	18.00%	15.54%	16.45%	13.00%	10.09%
Effective Tax Rate	4.97%	14.56%	19.11%	19.80%	38.83%	3.35%

SEC Filings: 10-K · 10-Q